444 related articles for article (PubMed ID: 31781506)
1. Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer.
Wang H; Wu X; Chen Y
Front Oncol; 2019; 9():1212. PubMed ID: 31781506
[No Abstract] [Full Text] [Related]
2. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer.
Liu Y; Wu J; Huang W; Weng S; Wang B; Chen Y; Wang H
J Transl Med; 2020 May; 18(1):201. PubMed ID: 32410620
[TBL] [Abstract][Full Text] [Related]
3. A signature of estimate-stromal-immune score-based genes associated with the prognosis of lung adenocarcinoma.
Ma Q; Chen Y; Xiao F; Hao Y; Song Z; Zhang J; Okuda K; Um SW; Silva M; Shimada Y; Si C; Liang C
Transl Lung Cancer Res; 2021 Mar; 10(3):1484-1500. PubMed ID: 33889524
[TBL] [Abstract][Full Text] [Related]
4. Stromal Score-Based Gene Signature: A Prognostic Prediction Model for Colon Cancer.
Jia J; Dai Y; Zhang Q; Tang P; Fu Q; Xiong G
Front Genet; 2021; 12():655855. PubMed ID: 34054919
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a Prognostic Signature of Stromal/Immune-Related Genes for Gastric Adenocarcinoma Based on ESTIMATE Algorithm.
Yu S; Wang Y; Peng K; Lyu M; Liu F; Liu T
Front Cell Dev Biol; 2021; 9():752023. PubMed ID: 34900998
[TBL] [Abstract][Full Text] [Related]
6. A Five-Gene Signature Based on Stromal/Immune Scores in the Tumor Microenvironment and Its Clinical Implications for Liver Cancer.
Liu X; Niu X; Qiu Z
DNA Cell Biol; 2020 Sep; 39(9):1621-1638. PubMed ID: 32758021
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancer.
Huo J; Guan G; Cai J; Wu L
World J Surg Oncol; 2022 Jan; 20(1):4. PubMed ID: 34983559
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Prognostic Signature Model with Tumor Microenvironment for predicting Disease-free Survival after Radical Prostatectomy.
Zhao H; Zhang X; Shi Z; Guo B; Zhang W; He K; Hu X; Shi S
J Cancer; 2021; 12(8):2371-2384. PubMed ID: 33758613
[No Abstract] [Full Text] [Related]
9. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Immune-Stromal Score-Based Gene Signature and Molecular Subtypes in Osteosarcoma: Implications for Prognosis and Tumor Immune Microenvironment.
Zheng D; Yang K; Chen X; Li Y; Chen Y
Front Genet; 2021; 12():699385. PubMed ID: 34630511
[No Abstract] [Full Text] [Related]
11. Identification of Prognostic Stromal-Immune Score-Based Genes in Hepatocellular Carcinoma Microenvironment.
Liu S; Yu G; Liu L; Zou X; Zhou L; Hu E; Song Y
Front Genet; 2021; 12():625236. PubMed ID: 33643387
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
13. Comprehensive Analysis Based on the Cancer Immunotherapy and Immune Activation of Gastric Cancer Patients.
Jiang F; Ma Q
Genet Res (Camb); 2023; 2023():4674536. PubMed ID: 36923953
[TBL] [Abstract][Full Text] [Related]
14. Stromal score as a prognostic factor in primary gastric cancer and close association with tumor immune microenvironment.
Mao M; Yu Q; Huang R; Lu Y; Wang Z; Liao L
Cancer Med; 2020 Jul; 9(14):4980-4990. PubMed ID: 32432377
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Wu M; Yuan H; Li X; Liao Q; Liu Z
Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
[No Abstract] [Full Text] [Related]
16. Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma.
Zhang W; Lyu P; Andreev D; Jia Y; Zhang F; Bozec A
Front Cell Dev Biol; 2022; 10():974851. PubMed ID: 36578780
[No Abstract] [Full Text] [Related]
17. Development and validation of nomogram with tumor microenvironment-related genes and clinical factors for predicting overall survival of endometrial cancer.
Chen Q; Wang S; Lang JH
J Cancer; 2021; 12(12):3530-3538. PubMed ID: 33995630
[No Abstract] [Full Text] [Related]
18. Integrating Tumor Stroma Biomarkers With Clinical Indicators for Colon Cancer Survival Stratification.
Chen Y; Wang W; Jiang B; Yao L; Xia F; Li X
Front Med (Lausanne); 2020; 7():584747. PubMed ID: 33365318
[TBL] [Abstract][Full Text] [Related]
19. A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer.
He R; Zuo S
Front Oncol; 2019; 9():693. PubMed ID: 31417870
[No Abstract] [Full Text] [Related]
20. A Novel RNA-Binding Protein Signature to Predict Clinical Outcomes and Guide Clinical Therapy in Gastric Cancer.
Qiu Z; Jiang H; Ju K; Liu X
Front Med (Lausanne); 2021; 8():670141. PubMed ID: 34336882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
